Here is a full clinical summary for a potassium of 2.5 mEq/L:
Hypokalemia - K+ 2.5 mEq/L
Severity: Moderate-to-Severe (Normal: 3.5-5.0 mEq/L)
A K+ of 2.5 mEq/L is below the threshold of 3.0 mmol/L that requires mandatory treatment. It is associated with a doubling of serious ventricular dysrhythmias, muscular weakness, and rhabdomyolysis. Urgent replacement is warranted.
Immediate Priorities
- Assess for emergency signs - muscle weakness, paralysis, ECG changes (U waves, T wave flattening, ST depression, QT prolongation)
- Get an ECG now - AHA guidelines recommend cardiac monitoring in hypokalemia with prolonged QT interval
- Check magnesium - hypomagnesemia causes refractory hypokalemia; must be corrected simultaneously
Clinical Workup
| Step | Action |
|---|
| History | Diuretics, laxatives, vomiting, diarrhea, licorice/herbal supplements |
| Exam | BP (HTN suggests hyperaldosteronism), volume status, signs of thyroid disease or Cushing's |
| Labs | BMP, Mg2+, Ca2+, phosphate, creatinine, urine K+, urine osmolality, urine Cl- |
| ECG | Mandatory at K+ < 3.0 |
Urine K+ helps localize the cause:
- < 15 mmol/day = extrarenal loss (GI losses, sweating, poor intake)
- > 15 mmol/day = renal wasting (diuretics, hyperaldosteronism, RTA, Bartter's, Gitelman's)
The diagnostic flowchart from Brenner and Rector's The Kidney is shown below:
Treatment
Potassium Replacement
Preferred salt: Potassium chloride (KCl) in most cases. KCl corrects hypokalemia faster than potassium bicarbonate, and replaces the chloride lost alongside K+ in vomiting/diuretic-induced cases.
- Potassium phosphate - if concurrent phosphate deficit (e.g., DKA)
- Potassium bicarbonate/citrate - if concurrent metabolic acidosis
Route & Rate
| Setting | Regimen |
|---|
| Asymptomatic, tolerating oral intake | KCl 40 mEq orally x 1 dose; recheck K+ 2h after |
| Asymptomatic, NPO | KCl 20 mEq IV q2h x 2 doses |
| Symptomatic | KCl 20 mEq IV q1h x 4 doses |
| Life-threatening arrhythmia | Up to 40 mEq/h IV with continuous ECG monitoring |
| Unmonitored setting | No more than 10 mEq/h IV |
- Recheck K+ 2 hours after end of infusion
- Use dextrose-free IV fluid - glucose triggers insulin release and can drop K+ further by 0.2-1.4 mmol/L
- Oral repletion can be surprisingly fast: 75 mmol oral K+ raises serum K+ by ~1.0-1.4 mmol/L in 60-90 min
Target Goals
| Patient Population | Target K+ |
|---|
| General | > 3.5 mEq/L |
| Heart failure, arrhythmia, MI, ischemic heart disease, digoxin use | ≥ 4.0 - 4.5 mEq/L |
| Hepatic encephalopathy risk | ~4.0 mEq/L |
Key Dangers at K+ 2.5
- Cardiac arrhythmias - risk is highest in elderly, organic heart disease, digoxin use
- Digoxin toxicity - hypokalemia enhances digoxin binding to cardiac Na+/K+-ATPase
- Rhabdomyolysis
- Diaphragmatic weakness / respiratory failure in severe cases
- Hepatic encephalopathy (increased renal ammoniagenesis)
- Insulin impairment - hypokalemia inhibits insulin release and worsens hyperglycemia
Refractory Hypokalemia?
Check and correct magnesium first. Hypomagnesemia reduces intracellular Mg2+ in principal cells, increases ROMK channel outward conductance, and drives ongoing kaliuresis. K+ replacement will fail until Mg2+ is corrected.
Sources: Brenner and Rector's The Kidney, 2-Vol Set (pp. 762-764); Schwartz's Principles of Surgery, 11th Ed. (pp. 122-123)